September 2018 – emka MEDICAL has successfully passed its recertification audit according to ISO 13485:2016. You can find our new certificates here.

July/August 2018 – Court registered shares for emka MEDICAL amended by 23,500 nominal shares, to attract investors in the last round before launching CE conform the first CorLog-Probe-1P for tricuspid valve monitoring application. Conditions see: in English, in German, reference to EIPP Portal (EU Portal for projects with Horizon-2020 grants):

May 2018 – Read our latest udpate for Cor/log Probe 1P here

September 2017 – The company name has been changed from CGS Sensors GmbH to emka MEDICAL GmbH since 18. September 2017

January 2017 – CGS becomes the eligible innovative company for the German funding program „INVEST – Zuschuss für Wagniskapital„, certified by BMWi (Federal Ministry for Economic Affairs and Energy, Germany).

September 2016 – A BayMED grant of 250k€ from the Free State of Bavaria has been awarded to develop the Cor/log Probe 1P with specific indications for use in jugular vein pressure monitoring of heart failure patients.

September 2016 – The clinical applications of Cor/log® BAN BT and Cor/log® View are presented by Prof. Dr. med. Thomas Hilbel, Heidelberg University Hospital, Department of Cardiology in the conference paper, „Cor/log BAN BT a Wearable Battery Powered mHealth Data Logger and Telemetry Unit for Multiple Vital Sign Monitoring „ , at the annual conference of Computing in Cardiology (CinC) 2016 in Vancouver, Canada.

February 2016 – The joint project CorLog proposed by our sister company MI Medical Innovation together with our French partner, emka TECHNOLOGIES, got granted with Horizon 2020 Seal of Excellence, issued by the European Commission on 8 February 2016.